New advances in genitourinary cancer: evidence gathered in 2014

C. Suárez, J. Puente, E. Gallardo, M. J. Méndez-Vidal, M. A. Climent, L. León, D. Olmos, X. García del Muro, E. González-Billalabeitia, E. Grande, J. Bellmunt, B. Mellado, P. Maroto, A. González del Alba

Producción científica: Contribución a una revistaArtículoInvestigaciónrevisión exhaustiva

4 Citas (Scopus)

Resumen

© 2015, Springer Science+Business Media New York. This review provides updated information published in 2014 regarding advances and major achievements in genitourinary cancer. Sections include the best in prostate cancer, renal cancer, bladder cancer, and germ cell tumors. In the field of prostate cancer, data related to treatment approach of hormone-sensitive disease, castrate-resistant prostate cancer, mechanisms of resistance, new drugs, and molecular research are presented. In relation to renal cancer, relevant aspects in the treatment of advanced renal cell carcinoma, immunotherapy, and molecular research, including angiogenesis and von Hippel-Lindau gene, molecular biology of non-clear cell histologies, and epigenetics of clear renal cell cancer are described. New strategies in the management of muscle-invasive localized bladder cancer and metastatic disease are reported as well as salient findings of biomolecular research in urothelial cancer. Some approaches intended to improve outcomes in poor prognosis patients with metastatic germ cell cancer are also reported. Results of clinical trials in these areas are discussed.
Idioma originalInglés
Páginas (desde-hasta)443-464
PublicaciónCancer and Metastasis Reviews
Volumen34
N.º3
DOI
EstadoPublicada - 25 sept 2015

Huella

Profundice en los temas de investigación de 'New advances in genitourinary cancer: evidence gathered in 2014'. En conjunto forman una huella única.

Citar esto